BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34763089)

  • 1. Adult-onset Still's disease following mRNA COVID-19 vaccination.
    Sharabi A; Shiber S; Molad Y
    Clin Immunol; 2021 Dec; 233():108878. PubMed ID: 34763089
    [No Abstract]   [Full Text] [Related]  

  • 2. Fever and dyspnea after anti-Covid-19 vaccination: a challenging diagnosis.
    Palladino M; Del Vecchio M; Farroni S; Martellucci O; Gigante A; Alessandri C; Muscaritoli M
    Intern Emerg Med; 2024 Apr; 19(3):757-760. PubMed ID: 37566358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still's disease.".
    Marques MC; Paul S; Lake C; Bergeron LL; Sinha R; Peixoto L; Twilt M; Ombrello MJ
    Pediatr Rheumatol Online J; 2023 Nov; 21(1):139. PubMed ID: 37990257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unprovoked Pulmonary Embolism Identified on Initial Presentation of Adult-Onset Still Disease in an Elderly Patient With No Malignancy.
    Bhamra M; Amarnani A; Ozeri D
    J Clin Rheumatol; 2020 Mar; 26(2):e40-e42. PubMed ID: 32073530
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lymphadenopathy simulating peripheral T-cell lymphoma in adult-onset Still's disease: report of a case].
    Ding B; Chen XY; Li YN; Gu QQ
    Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):625-627. PubMed ID: 38825913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell vasculitis post-COVID-19 mRNA vaccine and COVID-19 asymptomatic infection: Correspondence.
    Sookaromdee P; Wiwanitkit V
    Vascular; 2024 Apr; 32(2):475. PubMed ID: 36303407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination.
    Hansen E; Feldmann R; Pirker R; Jochmann J; Breier F; Posch C
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e6-e7. PubMed ID: 37709553
    [No Abstract]   [Full Text] [Related]  

  • 8. Gaining perspective on messenger RNA coronavirus disease 2019 vaccination risk.
    Heymann WR
    J Am Acad Dermatol; 2023 Sep; 89(3):476-477. PubMed ID: 37385451
    [No Abstract]   [Full Text] [Related]  

  • 9. Adult-onset Still's disease following pneumococcal vaccination.
    Sato T; Takeo N; Matsuda-Hirose H; Abe K; Nishida H; Hatano Y
    Eur J Dermatol; 2021 Aug; ():. PubMed ID: 34427562
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
    Avci E; Abasiyanik F
    J Autoimmun; 2021 Dec; 125():102745. PubMed ID: 34781161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study.
    Angyal A; Longet S; Moore SC; Payne RP; Harding A; Tipton T; Rongkard P; Ali M; Hering LM; Meardon N; Austin J; Brown R; Skelly D; Gillson N; Dobson SL; Cross A; Sandhar G; Kilby JA; Tyerman JK; Nicols AR; Spegarova JS; Mehta H; Hornsby H; Whitham R; Conlon CP; Jeffery K; Goulder P; Frater J; Dold C; Pace M; Ogbe A; Brown H; Ansari MA; Adland E; Brown A; Chand M; Shields A; Matthews PC; Hopkins S; Hall V; James W; Rowland-Jones SL; Klenerman P; Dunachie S; Richter A; Duncan CJA; Barnes E; Carroll M; Turtle L; de Silva TI;
    Lancet Microbe; 2022 Jan; 3(1):e21-e31. PubMed ID: 34778853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients.
    Massa F; Cremoni M; Gérard A; Grabsi H; Rogier L; Blois M; Couzin C; Hassen NB; Rouleau M; Barbosa S; Martinuzzi E; Fayada J; Bernard G; Favre G; Hofman P; Esnault VLM; Czerkinsky C; Seitz-Polski B; Glaichenhaus N; Sicard A
    EBioMedicine; 2021 Nov; 73():103679. PubMed ID: 34763205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report.
    Takeyama R; Fukuda K; Kouzaki Y; Koga T; Hayashi S; Ohtani H; Inoue T
    Acta Neurochir (Wien); 2022 Feb; 164(2):543-547. PubMed ID: 34783899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Booster or additional vaccination doses in patients vaccinated against COVID-19.
    García-Botella A; García-Lledó A; Gómez-Pavón J; González Del Castillo J; Hernández-Sampelayo T; Martín-Delgado MC; Martín Sánchez FJ; Martínez-Sellés M; Molero García JM; Moreno Guillén S; Rodríguez-Artalejo FJ; Ruiz-Galiana J; Cantón R; De Lucas Ramos P; Bouza E
    Rev Esp Quimioter; 2022 Apr; 35(2):105-114. PubMed ID: 34775740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan.
    Matsuzaki K; Aoki R; Nihei Y; Suzuki H; Kihara M; Yokoo T; Kashihara N; Narita I; Suzuki Y
    Clin Exp Nephrol; 2022 Apr; 26(4):316-322. PubMed ID: 34773533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.
    Davidov Y; Tsaraf K; Cohen-Ezra O; Likhter M; Ben Yakov G; Levy I; Levin EG; Lustig Y; Mor O; Rahav G; Ben Ari Z
    Liver Transpl; 2022 Feb; 28(2):215-223. PubMed ID: 34767690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-Onset Still Disease After ChAdOx1 nCOV-19 Vaccination.
    Weng J; Zhou LL; Hahn T; Shojania K; Dutz J
    J Rheumatol; 2023 Feb; 50(2):290-291. PubMed ID: 35970527
    [No Abstract]   [Full Text] [Related]  

  • 18. A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.
    Jeon YH; Lim DH; Choi SW; Choi SJ
    Rheumatol Int; 2022 Apr; 42(4):743-748. PubMed ID: 34797392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.
    Gebre MS; Rauch S; Roth N; Yu J; Chandrashekar A; Mercado NB; He X; Liu J; McMahan K; Martinot A; Martinez DR; Giffin V; Hope D; Patel S; Sellers D; Sanborn O; Barrett J; Liu X; Cole AC; Pessaint L; Valentin D; Flinchbaugh Z; Yalley-Ogunro J; Muench J; Brown R; Cook A; Teow E; Andersen H; Lewis MG; Boon ACM; Baric RS; Mueller SO; Petsch B; Barouch DH
    Nature; 2022 Jan; 601(7893):410-414. PubMed ID: 34794169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals.
    Collier AY; Yu J; McMahan K; Liu J; Atyeo C; Ansel JL; Fricker ZP; Pavlakis M; Curry MP; Jacob-Dolan C; Patel H; Sellers D; Barrett J; Rowe M; Ahmad K; Gompers A; Aguayo R; Chandrashekar A; Alter G; Hacker MR; Barouch DH
    J Infect Dis; 2022 Apr; 225(7):1124-1128. PubMed ID: 34792136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.